Meyahealth
HomeGeneticsGeneGLB1 gene
Back to Gene
GLB1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

GLB1 gene

The GLB1 gene is responsible for producing beta-galactosidase, an enzyme critical for recycling molecules within cells, and the elastin-binding protein, which supports the body's connective tissue framework.

Normal Function

The GLB1 gene provides instructions for producing two distinct proteins:

  • Beta-galactosidase (β-galactosidase): An enzyme located in lysosomes that breaks down substances such as GM1 ganglioside (essential for nerve cell function) and keratan sulfate (a sugar molecule found in cartilage and the cornea).
  • Elastin-binding protein: A protein found on the cell surface that interacts with cathepsin A and neuraminidase 1 to form the elastin receptor complex, which is involved in building elastic fibers in connective tissue.

Health Conditions Related to Genetic Changes

GM1 gangliosidosis

Variants in the GLB1 gene can cause GM1 gangliosidosis, a condition resulting from the loss of neurons in the brain and spinal cord. These variants produce a less effective version of β-galactosidase, causing toxic buildup of GM1 ganglioside and keratan sulfate. This accumulation leads to:

  • Intellectual disability
  • Movement problems
  • Cardiomyopathy (weakened heart muscle), potentially linked to altered elastin-binding protein

Mucopolysaccharidosis type IV

Variants in the GLB1 gene can also cause mucopolysaccharidosis type IV (MPS IV), a progressive condition primarily affecting the skeleton. These variants disrupt the breakdown of keratan sulfate, leading to its accumulation in cartilage and the cornea. Symptoms include:

  • Skeletal abnormalities
  • Cloudy corneas

Other Names for This Gene

  • BGAL_HUMAN
  • EBP
  • elastin receptor 1, 67kDa
  • ELNR1

Frequently Asked Questions

Parents should look for delayed motor milestones, such as difficulty sitting or walking, progressive muscle weakness, and speech delays. Early signs may also include seizures, abnormal eye movements, or a noticeable lack of coordination. If these symptoms appear, a pediatric neurologist should evaluate the child promptly.
The elastin‑binding protein helps maintain the elasticity of blood vessels and heart tissue. When GLB1 mutations reduce its function, elastic fibers become fragile, which can weaken the heart muscle and lead to cardiomyopathy. Regular cardiac imaging and monitoring of heart function are recommended for patients with GLB1‑related disorders.
Currently, no enzyme replacement therapy is approved specifically for GLB1 deficiency. However, patients may be eligible for experimental gene‑therapy trials or substrate‑reduction strategies being investigated in research settings. Patients should discuss trial options with a metabolic specialist or a clinical research coordinator at a tertiary care center.===
The diagnosis usually involves a combination of a genetic test (sequencing of the GLB1 gene from a blood sample) and an enzymatic assay measuring beta‑galactosidase activity in leukocytes or cultured fibroblasts. A skin biopsy may be needed if fibroblast testing is preferred. The results help distinguish GM1 gangliosidosis from other lysosomal storage diseases.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ